Why is Harrow, Inc. ?
- OPERATING CASH FLOW(Y) Highest at USD 17.68 MM
- ROCE(HY) Highest at -9.54%
- RAW MATERIAL COST(Y) Fallen by 0.43% (YoY)
- These investors have better capability and resources to analyse fundamentals of companies than most retail investors.
- Their stake has increased by 0.69% over the previous quarter.
How much should you buy?
- Overall Portfolio exposure to Harrow, Inc. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Harrow, Inc. for you?
High Risk, High Return
Quality key factors
Valuation Key Factors 
Technical key factors
Technical Movement
Highest at USD 17.68 MM
Highest at -9.54%
Fallen by 0.43% (YoY
Highest at 5.53 times
Highest at USD 71.64 MM
Highest at USD 19.64 MM
Highest at 27.42 %
Highest at USD 8.77 MM
Highest at USD 8.77 MM
Highest at 377.71 %
Lowest at 3.79 times
Here's what is working for Harrow, Inc.
Pre-Tax Profit (USD MM)
Net Profit (USD MM)
Operating Cash Flows (USD MM)
Net Sales (USD MM)
Net Sales (USD MM)
Operating Profit (USD MM)
Operating Profit to Sales
Pre-Tax Profit (USD MM)
Net Profit (USD MM)
Inventory Turnover Ratio
Raw Material Cost as a percentage of Sales
Here's what is not working for Harrow, Inc.
Debt-Equity Ratio
Debtors Turnover Ratio






